Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells.

Standard

Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells. / Deuse, Tobias; Seifert, Martina; Phillips, Neil; Fire, Andrew; Tyan, Dolly; Kay, Mark; Tsao, Philip S; Hua, Xiaoqin; Velden, Joachim; Eiermann, Thomas; Volk, Hans-Dieter; Reichenspurner, Hermann; Robbins, Robert C; Schrepfer, Sonja.

in: J CELL SCI, Jahrgang 124, Nr. Pt 17, Pt 17, 2011, S. 3029-3037.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Deuse, T, Seifert, M, Phillips, N, Fire, A, Tyan, D, Kay, M, Tsao, PS, Hua, X, Velden, J, Eiermann, T, Volk, H-D, Reichenspurner, H, Robbins, RC & Schrepfer, S 2011, 'Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells.', J CELL SCI, Jg. 124, Nr. Pt 17, Pt 17, S. 3029-3037. <http://www.ncbi.nlm.nih.gov/pubmed/21878509?dopt=Citation>

APA

Deuse, T., Seifert, M., Phillips, N., Fire, A., Tyan, D., Kay, M., Tsao, P. S., Hua, X., Velden, J., Eiermann, T., Volk, H-D., Reichenspurner, H., Robbins, R. C., & Schrepfer, S. (2011). Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells. J CELL SCI, 124(Pt 17), 3029-3037. [Pt 17]. http://www.ncbi.nlm.nih.gov/pubmed/21878509?dopt=Citation

Vancouver

Deuse T, Seifert M, Phillips N, Fire A, Tyan D, Kay M et al. Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells. J CELL SCI. 2011;124(Pt 17):3029-3037. Pt 17.

Bibtex

@article{48facd81588d45fab8434bfb48501796,
title = "Immunobiology of na{\"i}ve and genetically modified HLA-class-I-knockdown human embryonic stem cells.",
abstract = "Human embryonic stem cells (hESCs) can serve as a universal cell source for emerging cell or tissue replacement strategies, but immune rejection of hESC derivatives remains an unsolved problem. Here, we sought to describe the mechanisms of rejection for na{\"i}ve hESCs and upon HLA class I (HLA I) knockdown (hESC(KD)). hESCs were HLA I-positive but negative for HLA II and co-stimulatory molecules. Transplantation of na{\"i}ve hESC into immunocompetent Balb/c mice induced substantial T helper cell 1 and 2 (Th1 and Th2) responses with rapid cell death, but hESCs survived in immunodeficient SCID-beige recipients. Histology revealed mainly macrophages and T cells, but only scattered natural killer (NK) cells. A surge of hESC-specific antibodies against hESC class I, but not class II antigens, was observed. Using HLA I RNA interference and intrabody technology, HLA I surface expression of hESC(KD) was 88%-99% reduced. T cell activation after hESC(KD) transplantation into Balb/c was significantly diminished, antibody production was substantially alleviated, the levels of graft-infiltrating immune cells were reduced and the survival of hESC(KD) was prolonged. Because of their very low expression of stimulatory NK ligands, NK-susceptibility of na{\"i}ve hESCs and hESC(KD) was negligible. Thus, HLA I recognition by T cells seems to be the primary mechanism of hESC recognition, and T cells, macrophages and hESC-specific antibodies participate in hESC killing.",
keywords = "Animals, Humans, Male, Mice, Mice, Inbred BALB C, Transplantation, Heterologous, Mice, SCID, Embryonic Stem Cells/cytology/*immunology/*transplantation, Gene Knockdown Techniques/methods, Graft Rejection/genetics/*immunology, HLA Antigens/*genetics/*immunology, Animals, Humans, Male, Mice, Mice, Inbred BALB C, Transplantation, Heterologous, Mice, SCID, Embryonic Stem Cells/cytology/*immunology/*transplantation, Gene Knockdown Techniques/methods, Graft Rejection/genetics/*immunology, HLA Antigens/*genetics/*immunology",
author = "Tobias Deuse and Martina Seifert and Neil Phillips and Andrew Fire and Dolly Tyan and Mark Kay and Tsao, {Philip S} and Xiaoqin Hua and Joachim Velden and Thomas Eiermann and Hans-Dieter Volk and Hermann Reichenspurner and Robbins, {Robert C} and Sonja Schrepfer",
year = "2011",
language = "English",
volume = "124",
pages = "3029--3037",
journal = "J CELL SCI",
issn = "0021-9533",
publisher = "Company of Biologists Ltd",
number = "Pt 17",

}

RIS

TY - JOUR

T1 - Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells.

AU - Deuse, Tobias

AU - Seifert, Martina

AU - Phillips, Neil

AU - Fire, Andrew

AU - Tyan, Dolly

AU - Kay, Mark

AU - Tsao, Philip S

AU - Hua, Xiaoqin

AU - Velden, Joachim

AU - Eiermann, Thomas

AU - Volk, Hans-Dieter

AU - Reichenspurner, Hermann

AU - Robbins, Robert C

AU - Schrepfer, Sonja

PY - 2011

Y1 - 2011

N2 - Human embryonic stem cells (hESCs) can serve as a universal cell source for emerging cell or tissue replacement strategies, but immune rejection of hESC derivatives remains an unsolved problem. Here, we sought to describe the mechanisms of rejection for naïve hESCs and upon HLA class I (HLA I) knockdown (hESC(KD)). hESCs were HLA I-positive but negative for HLA II and co-stimulatory molecules. Transplantation of naïve hESC into immunocompetent Balb/c mice induced substantial T helper cell 1 and 2 (Th1 and Th2) responses with rapid cell death, but hESCs survived in immunodeficient SCID-beige recipients. Histology revealed mainly macrophages and T cells, but only scattered natural killer (NK) cells. A surge of hESC-specific antibodies against hESC class I, but not class II antigens, was observed. Using HLA I RNA interference and intrabody technology, HLA I surface expression of hESC(KD) was 88%-99% reduced. T cell activation after hESC(KD) transplantation into Balb/c was significantly diminished, antibody production was substantially alleviated, the levels of graft-infiltrating immune cells were reduced and the survival of hESC(KD) was prolonged. Because of their very low expression of stimulatory NK ligands, NK-susceptibility of naïve hESCs and hESC(KD) was negligible. Thus, HLA I recognition by T cells seems to be the primary mechanism of hESC recognition, and T cells, macrophages and hESC-specific antibodies participate in hESC killing.

AB - Human embryonic stem cells (hESCs) can serve as a universal cell source for emerging cell or tissue replacement strategies, but immune rejection of hESC derivatives remains an unsolved problem. Here, we sought to describe the mechanisms of rejection for naïve hESCs and upon HLA class I (HLA I) knockdown (hESC(KD)). hESCs were HLA I-positive but negative for HLA II and co-stimulatory molecules. Transplantation of naïve hESC into immunocompetent Balb/c mice induced substantial T helper cell 1 and 2 (Th1 and Th2) responses with rapid cell death, but hESCs survived in immunodeficient SCID-beige recipients. Histology revealed mainly macrophages and T cells, but only scattered natural killer (NK) cells. A surge of hESC-specific antibodies against hESC class I, but not class II antigens, was observed. Using HLA I RNA interference and intrabody technology, HLA I surface expression of hESC(KD) was 88%-99% reduced. T cell activation after hESC(KD) transplantation into Balb/c was significantly diminished, antibody production was substantially alleviated, the levels of graft-infiltrating immune cells were reduced and the survival of hESC(KD) was prolonged. Because of their very low expression of stimulatory NK ligands, NK-susceptibility of naïve hESCs and hESC(KD) was negligible. Thus, HLA I recognition by T cells seems to be the primary mechanism of hESC recognition, and T cells, macrophages and hESC-specific antibodies participate in hESC killing.

KW - Animals

KW - Humans

KW - Male

KW - Mice

KW - Mice, Inbred BALB C

KW - Transplantation, Heterologous

KW - Mice, SCID

KW - Embryonic Stem Cells/cytology/immunology/transplantation

KW - Gene Knockdown Techniques/methods

KW - Graft Rejection/genetics/immunology

KW - HLA Antigens/genetics/immunology

KW - Animals

KW - Humans

KW - Male

KW - Mice

KW - Mice, Inbred BALB C

KW - Transplantation, Heterologous

KW - Mice, SCID

KW - Embryonic Stem Cells/cytology/immunology/transplantation

KW - Gene Knockdown Techniques/methods

KW - Graft Rejection/genetics/immunology

KW - HLA Antigens/genetics/immunology

M3 - SCORING: Journal article

VL - 124

SP - 3029

EP - 3037

JO - J CELL SCI

JF - J CELL SCI

SN - 0021-9533

IS - Pt 17

M1 - Pt 17

ER -